About

Coronary artery disease (CAD) is one of the most common causes of death worldwide. It is responsible for one-third of deaths in people over 35 years old, with the percentage reaching close to 50% (according to some estimates) in western countries.

The existing treatment is medical, surgical or a combination of both depending on the extent, severity and clinical presentation of CAD & .There has been significant progress made in developing novel strategies for patients suffering from CAD and its associated complications. These strategies have ranged from drugs to robotic surgery to nanotechnology.

Articles

ISCHEMIA: A Clinician’s Perspective

Published:

31 August 2020

Citation:

European Cardiology Review 2020;15:e63.

Atherosclerotic CVD Risk and Advanced Lipid Testing

Published:

15 July 2020

Citation:

European Cardiology Review 2020;15:e56.

Influence of Combined Therapy on Inflammatory State and Pro-inflammatory Cytokines in Patients with Coronary Artery Disease and Metabolic Syndrome

Citation:

European Cardiology Review 2020;15:e27.

Statins in Non-obstructive Coronary Artery Disease

Published:

08 April 2020

Citation:

European Cardiology Review 2020;15:e15.